Mini Review
Published on 27 Nov 2018
Targeting Inflammation With Nanosized Drug Delivery Platforms in Cardiovascular Diseases: Immune Cell Modulation in Atherosclerosis
in Nanobiotechnology
Frontiers in Bioengineering and Biotechnology
doi 10.3389/fbioe.2018.00177
- 8,497 views
- 35 citations





